Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2021-06-07 Transaction in Own Shar…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 100% confidence The document provides a detailed, itemized list of share transactions (volume, price, venue, and timestamp) executed by Genmab as part of a share buyback program for the period of May 31 to June 4, 2021. This is a direct report of the company's activity in buying back its own shares, which falls under the 'Transaction in Own Shares' category.
2021-06-07 English
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 100% confidence The document is a formal company announcement detailing specific transactions executed under a share buy-back program. It provides a table of daily share repurchases, the total value, and the updated treasury share position. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2021-06-07 English
Transaction in Own Shares 2021
Transaction in Own Shares Classification · 99% confidence The document is titled "Transactions in connection with share buy-back program" and details the number of shares bought back by the company (Genmab A/S) during a specific period (May 31, 2021 to June 4, 2021). This activity directly relates to the company managing its own stock, which falls under the definition of 'Transaction in Own Shares'. The document explicitly reports on the execution of a share buy-back program, which corresponds to the 'POS' filing type code.
2021-06-07 English
6-K
Foreign Filer Report
2021-06-01 English
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 100% confidence The document is a detailed, tabular list of individual share transactions (volume, price, venue, and timestamp) executed by Genmab as part of a share buyback program. This type of disclosure is a standard regulatory requirement for companies conducting share repurchases to provide transparency on their own share transactions. According to the filing definitions, 'Transaction in Own Shares' (POS) is the specific category for reports of a company buying back its own shares.
2021-05-31 English
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 100% confidence The document is a formal company announcement from Genmab detailing specific transactions executed under a share buy-back program. It provides a table of daily share repurchases, the total number of shares acquired, and the impact on treasury shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2021-05-31 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.